{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:40:00Z","timestamp":1792687200005,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05759-9","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:55:24Z","timestamp":1792641324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic potential of combined PPAR\u03b3 agonist and MEK inhibitor treatment in modulating lipid metabolism and adipogenic reprogramming of breast cancer cells"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3371-0127","authenticated-orcid":false,"given":"Zeynep Do\u011fru","family":"K\u00f6seo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-9743","authenticated-orcid":false,"given":"Feyza","family":"Bayramo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-7691","authenticated-orcid":false,"given":"Abdullah H\u00fcseyin","family":"K\u00f6seo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2672-6507","authenticated-orcid":false,"given":"Erdal F\u0131rat","family":"\u00c7aralan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-7148","authenticated-orcid":false,"given":"Akif","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0675-1839","authenticated-orcid":false,"given":"Turkan","family":"Yi\u011fitba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"5759_CR1","unstructured":"Chhikara BS, Parang K (2023) Global Cancer Statistics 2022: the trends projection analysis. Chem Biology Lett 10"},{"key":"5759_CR2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, Mccormack V et al (2025) nature medicine Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med | 31:1154\u20131162. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med |"},{"key":"5759_CR3","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1002\/jcp.25797","volume":"232","author":"T Chen","year":"2017","unstructured":"Chen T, You Y, Jiang H, Wang ZZ (2017) Epithelial\u2013mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol 232:3261\u20133272","journal-title":"J Cell Physiol"},{"key":"5759_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccell.2018.12.002","volume":"35","author":"D Ishay-Ronen","year":"2019","unstructured":"Ishay-Ronen D, Diepenbruck M, Kalathur RKR et al (2019) Gain Fat\u2014Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis. Cancer Cell 35:17\u201332e6. https:\/\/doi.org\/10.1016\/j.ccell.2018.12.002","journal-title":"Cancer Cell"},{"key":"5759_CR5","doi-asserted-by":"crossref","unstructured":"Fahy E, Subramaniam S, Murphy RC et al (2009) Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 50","DOI":"10.1194\/jlr.R800095-JLR200"},{"key":"5759_CR6","doi-asserted-by":"crossref","unstructured":"Yoshida GJ (2015) Metabolic reprogramming: The emerging concept and associated therapeutic strategies. J Experimental Clin Cancer Res 34","DOI":"10.1186\/s13046-015-0221-y"},{"key":"5759_CR7","doi-asserted-by":"crossref","unstructured":"Huang C, Freter C (2015) Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci 16","DOI":"10.3390\/ijms16010924"},{"key":"5759_CR8","unstructured":"Berger J, Moller DE (2001) THE MECHANISMS OF ACTION OF PPARS"},{"key":"5759_CR9","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2217\/pgs.14.162","volume":"15","author":"D Della-Morte","year":"2014","unstructured":"Della-Morte D, Palmirotta R, Rehni AK et al (2014) Pharmacogenomics and pharmacogenetics of thiazolidinediones: Role in diabetes and cardiovascular risk factors. Pharmacogenomics 15:2063\u20132082","journal-title":"Pharmacogenomics"},{"key":"5759_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.coph.2005.04.007","volume":"5","author":"N Thompson","year":"2005","unstructured":"Thompson N, Lyons J (2005) Recent progress in targeting the Raf\/MEK\/ERK pathway with inhibitors in cancer drug discovery. Curr Opin Pharmacol 5:350\u2013356. https:\/\/doi.org\/10.1016\/j.coph.2005.04.007","journal-title":"Curr Opin Pharmacol"},{"key":"5759_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/CAD.0000000000000063","volume":"25","author":"MC Wani","year":"2014","unstructured":"Wani MC, Horwitz SB (2014) Nature as a Remarkable Chemist: A Personal Story of the Discovery and Development of Taxol\u00ae. Anticancer Drugs 25:482. https:\/\/doi.org\/10.1097\/CAD.0000000000000063","journal-title":"Anticancer Drugs"},{"key":"5759_CR12","doi-asserted-by":"publisher","unstructured":"Waldmeier L, Meyer-Schaller N, Diepenbruck M, Christofori G (2012) Py2T Murine Breast Cancer Cells, a Versatile Model of TGF\u03b2-Induced EMT In Vitro and In Vivo. PLoS ONE 7. https:\/\/doi.org\/10.1371\/journal.pone.0048651","DOI":"10.1371\/journal.pone.0048651"},{"key":"5759_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5732\/CJC.011.10226","volume":"30","author":"Y Wang","year":"2011","unstructured":"Wang Y, Zhou BP (2011) Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer 30:603\u2013611. https:\/\/doi.org\/10.5732\/CJC.011.10226","journal-title":"Chin J Cancer"},{"key":"5759_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C (2019) EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol 29:212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001","journal-title":"Trends Cell Biol"},{"key":"5759_CR15","doi-asserted-by":"publisher","first-page":"71151","DOI":"10.18632\/ONCOTARGET.9463","volume":"7","author":"AM Gonzalez-Guerrico","year":"2016","unstructured":"Gonzalez-Guerrico AM, Espinoza I, Schroeder B et al (2016) Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer. Oncotarget 7:71151\u201371168. https:\/\/doi.org\/10.18632\/ONCOTARGET.9463","journal-title":"Oncotarget"},{"key":"5759_CR16","doi-asserted-by":"publisher","first-page":"682911","DOI":"10.3389\/FONC.2021.682911","volume":"11","author":"I Giacomini","year":"2021","unstructured":"Giacomini I, Gianfanti F, Desbats MA et al (2021) Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy. Front Oncol 11:682911. https:\/\/doi.org\/10.3389\/FONC.2021.682911","journal-title":"Front Oncol"},{"key":"5759_CR17","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0275","author":"JL Sottnik","year":"2024","unstructured":"Sottnik JL, Shackleford MT, Robinson SK et al (2024) WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers. Cancer Res Commun. https:\/\/doi.org\/10.1158\/2767-9764.CRC-23-0275. 4:","journal-title":"Cancer Res Commun"},{"key":"5759_CR18","doi-asserted-by":"publisher","unstructured":"Germain N, Dhayer M, Boileau M et al (2020) Lipid Metabolism and Resistance to Anticancer Treatment. Biology 2020, Vol 9, Page 474 9:474. https:\/\/doi.org\/10.3390\/BIOLOGY9120474","DOI":"10.3390\/BIOLOGY9120474"},{"key":"5759_CR19","doi-asserted-by":"publisher","unstructured":"Rybinska I, Mangano N, Tagliabue E, Triulzi T (2021) Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/IJMS22073775","DOI":"10.3390\/IJMS22073775"},{"key":"5759_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/J.CANLET.2021.04.023","volume":"511","author":"F Ligorio","year":"2021","unstructured":"Ligorio F, Pellegrini I, Castagnoli L et al (2021) Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer. Cancer Lett 511:77\u201387. https:\/\/doi.org\/10.1016\/J.CANLET.2021.04.023","journal-title":"Cancer Lett"},{"key":"5759_CR21","doi-asserted-by":"publisher","unstructured":"Kavanagh EL, Lindsay S, Halasz M et al (2017) Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells. Oncogenesis 6. https:\/\/doi.org\/10.1038\/ONCSIS.2017.82","DOI":"10.1038\/ONCSIS.2017.82"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05759-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05759-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05759-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:03:16Z","timestamp":1792684996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05759-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":21,"alternative-id":["5759"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05759-9","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were reviewed and approved by the Non-Interventional Clinical Research Ethics Committee of Istanbul Medipol University (Approval No. E-10840098-772.02-1947).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}